Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Schizophrenia Study Clinical Trials References presented on Clinical Trials Search is not intended to be a substitute for proven healthcare advice, trips or professional assistance by using a real medical. We aren't mDs. Always confer with your physician about Schizophrenia Study conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Schizophrenia Study Clinical research trials and Schizophrenia Study medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectualness of new does drugs. The purpose of the studies / projects is to solve specific human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to discover treatments for all sorts of conditions, such as Schizophrenia Study. Schizophrenia Study Clinical Trials and other clinical trials permit volunteers to access healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for without cost, and every now and again they are compensated for their time. Sometimes there is a cost for a Schizophrenia Study clinical trial. Subjects often receive the most expert healthcare possible for their Schizophrenia Study condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, healthcare dangers (perhaps life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with stern guidelines to protect clinical trials subjects.

Home > "S" Clinical Trials Conditions > Schizophrenia Study

Schizophrenia Study



Schizophrenia Study

For Condition: Schizophrenia
Status: Completed
Sponsor(s): Sponsor Name Pending ,
Synopsis: A Placebo Controlled Study For Patients With Schizophrenia
Details:
Eligibility:
Study Type:
  Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/65 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: (Patients must meet this criteria in order to be eligible for this study.) - Patient must meet diagnostic criteria for schizophrenia. Exclusion Criteria: (Patients cannot meet these criteria in order to be eligible for this study.) - Patients with other psychotic disorders. - Patients whose condition is due to the direct physiological effects of a substances (e.g., drug abuse) or a general medical condition. - Patients with a history of autistic disorder or another pervasive developmental disorder. - Patients with epilepsy or a history of seizures requiring treatment. - Patients who are excluded from taking the drug risperidone. - Patients who pose a current serious suicidal or homicidal risk. - Patients who are adequately stabilized on their treatment.
Total Enrollment: 

Location and Contact Information:

Study Site
Pico Rivera,  California,  90660
United States
 

Study Site
San Diego,  California,  92126
United States
 

Study Site
Scottsdale,  Arizona,  85251
United States
 

Study Site
Terrell,  Texas,  75160
United States
 

Study Site
New Britain,  Connecticut,  06050
United States
 

Study Site
Butner,  North Carolina,  27509
United States
 

Study Site
Tampa,  Florida,  33613
United States
 

Study Site
Norman,  Oklahoma,  73069
United States
 

Study Site
Washington D.C.,  District of Columbia,  20016
United States
 

Study Site
Holliswood,  New York,  11423
United States
 

Study Site
Winter Park,  Florida,  32789
United States
 

Study Site
Sacramento,  California,  95823
United States
 

Study Site
Austin,  Texas,  78729
United States
 

Study Site
New Haven,  Connecticut,  06519
United States
 

Study Site
San Diego,  California,  92123
United States
 

Study Site
Greenwood,  Indiana,  46143
United States
 

Study Site
Bellaire,  Texas,  77401
United States
 

Study Site
Baltimore,  Maryland,  21202
United States
 

Study Site
Shreveport,  Louisiana,  71101
United States
 

Study Site
Clementon,  New Jersey,  08021
United States
 

Study Site
Nashville,  Tennessee,  37212
United States
 

Study Site
Rosemead,  California,  91770
United States
 

Study Site
Hoffman Estates,  Illinois,  60194
United States
 

Study Site
Orange,  California,  92868
United States
 

Study Site
Miami,  Florida,  33161
United States
 

Study Site
Cincinnati,  Ohio,  45267
United States
 

Study Site
Cerritos,  California,  90703
United States
 

Study Site
Miami,  Florida,  33161
United States
 

Study Site
Garden Grove,  California,  92845
United States
 

Study Site
Cleveland,  Ohio,  44109
United States
 

Study Site
Oklahoma City,  Oklahoma,  73103
United States
 

Study Site
Chapel Hill,  North Carolina,  27599
United States
 


Additional Information:
Study ID Numbers:
  SB223412/078; 
Study Start Date: 
Record last reviewed: January 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00049946

Other Schizophrenia Studies:
1. Depakote ER plus an atypical antipsychotic vs. an atypical antipsychotic alone in the treatment of schizophrenia

2. A Study of Galantamine as an Adjunctive Treatment to Atypical Antipsychotics in Schizophrenia Patients with Cognitive Deficits

3. Glucose regulation during risperidone and olanzapine treatment

4. Safety and Tolerability Study of Drug to Treat Schizophrenia

5. Treatment Response to Rehabilitation in Patients with Schizophrenia

Related Studies:

Other Schizophrenia Clinical Trials
Other New York Clinical Trials
Other Holliswood Clinical Trials

Schizophrenia Study

Modify your Search

  Other Schizophrenia Clinical Trials
  Other New York Clinical Trials
  Other Holliswood Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103